http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MA-29215-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
filingDate 2007-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16cf297719f2c99776c00b67d837825d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82596724f743e5f06de30446e230477e
publicationDate 2008-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MA-29215-B1
titleOfInvention PYRAZOLO [3,4-B] PYRIDINES AND THERAPEUTIC INDAZOLES
abstract THE INVENTION CONCERNS COMPOUNDS OF FORMULA (I), IN WHICH R2, R3, R4, R5, R6, R7, X, AND L REPRESENT ONE OF THE VALUES DEFINED IN THE SPECIFICATION, AND ACCEPTABLE PHARMACEUTICALLY ASSOCIATED SALTS, WHICH ARE USED IN AS AGENTS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS AND OTHER DISORDERS, INCLUDING, HYPERACTIVITY DISORDER WITH ATTENTION DEFICIT, NEUROPATHIC PAIN, URINARY INCONTINENCE, ANXIETY, DEPRESSION, SCHIZOPHRENIA AND FIBROMYALGIA. This invention is also directed to pharmaceutical compositions containing at least one compound of Formula (I).
priorityDate 2004-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21057622

Total number of triples: 30.